The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
This study is creating a collection of information (repository) about children and adults in the U.S. who have homozygous familial hypercholesterolemia (hoFH). This is a very rare condition where you inherit an abnormal gene from both parents, leading to very high cholesterol levels from birth. The goal is to better understand how hoFH affects health over time and how different treatments impact the arteries. Researchers will gather detailed medical information, including blood tests, heart evaluations, and imaging of your arteries. They will also collect information on treatments like statins, ezetimibe, LDL-apheresis, and liver transplant. This will help doctors learn the best ways to monitor and treat hoFH. To join, you must have hoFH, confirmed by very high LDL cholesterol levels (over 500 mg/dL) and/or genetic testing.
- Study design
- This is an observational study, meaning researchers will collect information without providing specific interventions. It aims to enroll 60 participants.
- What's involved
- Participants will undergo medical history and physical exams, blood tests, dietary evaluations, and cardiology evaluations including EKG, echocardiogram, and artery ultrasounds. Some may also have CT angiograms or other heart procedures. Medical photos of skin xanthomas and additional blood tests will also be taken.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study will track changes in disease progression over 10 years.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lisa C. Hudgins, M.D. · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Change in disease progression10 years